Steven P. Sparagana MD
Neurodevelopmental Disabilities
Assistant Professor, Neurology & Neurotherapeutics, University of Texas
Request Appointment
2222 Welborn StDallas, TX 75219
Fax+1 214-559-8383
Overview of Dr. Sparagana
Dr. Steven Sparagana is a Child Neurologist in Dallas, TX. He received his medical degree from The University of Texas Health Science Center at San Antonio and has been in practice 36 years. He has more than 40 publications and over 500 citings.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Clinical Neurophysiology, 1997 - 1998- University of Texas Southwestern Medical CenterFellowship, Child Neurology, 1991 - 1994
Washington University/B-JH/SLCH ConsortiumInternship, Transitional Year, 1989 - 1990
The University of Texas Health Science Center at San AntonioClass of 1989
Certifications & Licensure
MT State Medical License 1993 - 2027
TX State Medical License 1994 - 2026
American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Neurodevelopmental Disabilities
Publications & Presentations
PubMed
- Upper extremity neuromonitoring changes are more common than lower extremity during spinal fusion for Scheuermann's kyphosis.John Ghazi, Steven Sparagana, Patricia Rampy, Daniel Sucato, Megan Johnson
Spine Deformity. 2023-09-01 - 47 citationsLong-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial.Elizabeth A Thiele, E Martina Bebin, Francis Filloux, Patrick Kwan, Rachael Loftus
Epilepsia. 2022-02-01 - 11 citationsMultivariate data analysis identifies natural clusters of Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders (TAND)Petrus J. de Vries, Loren Leclezio, Sugnet Gardner-Lubbe, Darcy A. Krueger, Mustafa Sahin
Orphanet Journal of Rare Diseases. 2021-10-24
Press Mentions
The Role of the TSC Alliance in Advancing Therapy Development: A Patient Organization PerspectiveAugust 8th, 2024
